Provided by Tiger Fintech (Singapore) Pte. Ltd.

Solid Biosciences

3.12
-0.2900-8.52%
Post-market: 3.07-0.0490-1.57%19:36 EDT
Volume:1.61M
Turnover:5.11M
Market Cap:241.39M
PE:-1.02
High:3.40
Open:3.34
Low:3.06
Close:3.41
Loading ...

Solid Biosciences: Promising Advancements in Gene Therapy and Strategic Positioning Justify Buy Rating

TIPRANKS
·
08 Jan

Truist Initiates Solid Biosciences at Buy With $16 Price Target

MT Newswires Live
·
08 Jan

Solid Biosciences Inc : Truist Securities Initiates Coverage With Buy Rating; Price Target $16

THOMSON REUTERS
·
08 Jan

Solid Biosciences gains 12% to $4.40 on FDA clearance of SGT-212 IND

TIPRANKS
·
08 Jan

Solid Biosciences' Friedreich's Ataxia Treatment Application Gets FDA Clearance; Shares Rise After Hours

MT Newswires Live
·
08 Jan

Solid Biosciences Gains FDA Clearance for New Drug Application

Dow Jones
·
08 Jan

Solid Biosciences announces FDA clearance of SGT-212 IND application

TIPRANKS
·
08 Jan

BRIEF-Solid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich’s Ataxia

Reuters
·
08 Jan

Solid Biosciences Inc: Phase 1B Clinical Trial Initiation Expected in 2H 2025

THOMSON REUTERS
·
08 Jan

Solid Biosciences Announces FDA Ind Clearance for First-in-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich’s Ataxia

THOMSON REUTERS
·
08 Jan

BRIEF-Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
06 Jan

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
06 Jan

Solid Biosciences Joins Nasdaq Biotechnology Index Dec. 23

MT Newswires Live
·
24 Dec 2024

BRIEF-Solid Biosciences Added To The Nasdaq Biotechnology Index

Reuters
·
24 Dec 2024

Solid Biosciences added to Nasdaq Biotechnology Index

TIPRANKS
·
24 Dec 2024

Solid Biosciences Added to the Nasdaq Biotechnology Index

THOMSON REUTERS
·
24 Dec 2024

Solid Biosciences Added to the Nasdaq Biotechnology Index

GlobeNewswire
·
24 Dec 2024

Solid Biosciences Receives Buy Rating Amid Promising Developments and Accelerated Approval Prospects for SGT-003

TIPRANKS
·
23 Dec 2024

Solid Biosciences Positioned For Next-Gen Duchenne Muscular Dystrophy Treatment Success: Analyst

Benzinga
·
14 Dec 2024

Wedbush Initiates Solid Biosciences at Outperform With $16 Price Target

MT Newswires Live
·
13 Dec 2024